VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
BAX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
BAXBaxter International Inc.
$26.73$13.8B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBAXBalance Sheet

Baxter International Inc. (BAX) Balance Sheet

30Y historyFree accessUpdated daily

Debt-to-equity remains elevated at 1.56, with cash covering only 22% of total debt, indicating a thin liquidity buffer despite asset reduction to $19.8B.

BAX Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets6.99B6.87B8.85B9.6B8.01B8.87B8.41B7.5B5.96B7.26B6.57B11.8B10.16B10.2B9.26B8.65B7.99B8.27B7.15B7.55B6.97B5.12B6.02B5.36B5.16B3.98B3.65B3.82B4.29B3.87B3.48B
Cash & Short-Term Investments2.15B1.97B1.76B3.08B1.72B2.95B3.73B3.33B1.84B3.39B2.8B7.36B2.92B2.73B3.27B2.9B2.69B2.79B2.13B2.54B2.48B841M1.11B925M1.17B582M579M606M709M465M761M
Cash Only2.15B1.97B1.76B3.08B1.72B2.95B3.73B3.33B1.84B3.39B2.8B2.21B2.92B2.73B3.27B2.9B2.69B2.79B2.13B2.54B2.48B841M1.11B925M1.17B582M579M606M709M465M761M
Short-Term Investments000000000005.15B0000000000000000000
Accounts Receivable1.86B1.93B1.73B1.77B2.62B2.71B2.08B1.9B1.84B1.79B1.69B1.73B1.88B2.91B2.42B2.42B2.27B2.3B1.98B2.03B1.84B1.77B2.09B1.91B1.84B1.62B1.54B1.65B1.75B1.74B1.49B
Days Sales Outstanding57.7862.7259.3762.4395.281.5364.9560.9160.5161.8360.7363.3864.15112.8863.5163.5864.3766.8958.5365.6664.6465.4580.2678.4682.8380.4884.0494.51111.69120.6999.67
Inventory2.26B2.23B2.05B1.92B2.68B2.45B1.92B1.65B1.67B1.48B1.43B1.6B1.58B3.5B2.8B2.63B2.37B2.56B2.36B2.33B2.07B1.93B2.13B2.1B1.75B1.34B1.16B1.12B1.17B1.21B883M
Days Inventory Outstanding105.44103.58112.27112.73150.25120.5798.6991.495.9788.1186.32100.5693.78243.22150.41140.09125.7154.6138.59148.31133.68122.07139.31155.11147.64124.1116.19126.7151.26171.56119.5
Other Current Assets724M479M2.95B2.51B618M390M342M315M404M368M391M680M3.68B504M344M295M323M226M251M261M231M260M297M140M125M82M371M445M673M458M351M
Total Non-Current Assets12.8B13.18B16.93B18.68B20.28B24.65B11.61B10.69B9.76B9.85B8.97B9.17B15.98B15.03B11.13B10.42B9.5B9.08B8.26B7.74B7.72B7.61B8.13B8.35B7.32B6.37B5.08B5.83B5.58B4.84B4.12B
Property, Plant & Equipment3.17B3.19B3.18B3.21B5.24B5.81B5.33B5.12B4.53B4.59B4.29B4.39B4.43B7.83B6.1B5.53B5.26B5.16B4.61B4.49B4.23B4.14B4.37B4.59B3.91B3.31B2.81B2.65B2.44B2.36B1.84B
Fixed Asset Turnover3.63x3.53x3.35x3.23x1.92x2.09x2.19x2.22x2.45x2.31x2.37x2.27x2.42x1.20x2.29x2.51x2.44x2.43x2.68x2.51x2.45x2.38x2.18x1.94x2.07x2.23x2.39x2.41x2.33x2.23x2.95x
Goodwill4.89B4.93B5.28B5.79B6.45B9.84B3.22B3.03B3B3.1B2.6B2.69B2.93B4.21B2.5B2.32B2.02B1.82B1.65B1.69B1.62B1.55B000000000
Intangible Assets4.07B4.37B5.22B5.92B6.79B7.79B1.67B1.47B1.41B1.37B1.11B1.35B1.62B2.29B814M826M500M513M390M455M480M494M2.19B2.26B2.02B1.7B1.24B921M930M1.62B1.39B
Long-Term Investments342M103M109M136M247M195M135M76M44M0000000000000000000000
Other Non-Current Assets669M596M2.94B3.36B1.27B642M512M372M292M379M348M390M6.46B657M560M632M586M491M472M418M453M1.42B1.56B1.5B1.39B1.36B1.04B2.25B2.2B855M887M
Total Assets19.79B20.05B25.78B28.28B28.29B33.52B20.02B18.19B15.72B17.11B15.55B20.96B26.14B25.22B20.39B19.07B17.49B17.35B15.4B15.29B14.69B12.73B14.15B13.71B12.48B10.34B8.73B9.64B9.87B8.71B7.6B
Asset Turnover0.57x0.56x0.41x0.37x0.36x0.36x0.58x0.62x0.71x0.62x0.65x0.48x0.41x0.37x0.68x0.73x0.73x0.72x0.80x0.74x0.71x0.77x0.67x0.65x0.65x0.71x0.77x0.66x0.58x0.60x0.72x
Asset Growth %-56.05%-22.21%-8.82%-0.04%-15.61%67.45%10.04%15.73%-8.13%10.07%-25.84%-19.8%3.62%23.71%6.91%9.06%0.78%12.65%0.73%4.14%15.39%-10.04%3.21%9.85%20.64%18.44%-9.45%-2.32%13.39%14.63%-19.51%
Total Current Liabilities3.59B2.97B6.51B6.5B4.75B4.24B3.33B3.23B2.81B2.82B2.74B5.75B6.04B5.25B4.76B4.86B4.04B4.46B3.63B3.81B3.61B4.17B4.29B3.8B3.85B3.29B3.37B2.7B2.83B2.56B2.44B
Accounts Payable1.03B999M968M881M1.11B1.25B1.04B892M998M920M791M716M677M1.1B766M795M745M807M829M920M878M3.24B3.92B3.11B3.04B708M1.99B1.8B2.02B1.96B442M
Days Payables Outstanding46.3346.3653.1151.7862.2561.2453.7349.3257.4654.9647.7544.8940.2676.6741.142.3839.548.7948.6658.4656.81205.52256.1229.06257.4665.52199.49204.92262.34278.7959.82
Short-Term Debt844M84M2.75B2.67B1.4B511M406M541M4M3M3M2.58B1.7B1.04B350M446M24M711M394M425M234M924M361M153M220M201M634M255M271M144M346M
Deferred Revenue (Current)141M141M131M128M154M162M32M000009M760M878M738M635M00000000000000
Other Current Liabilities01.22B1.53B1.64B618M751M555M584M576M648M744M867M2.04B191M755M895M1.72B482M265M122M000538M588M661M748M640M536M450M1.66B
Current Ratio1.95x2.31x1.36x1.48x1.69x2.09x2.52x2.32x2.12x2.57x2.40x2.05x1.68x1.94x1.95x1.78x1.98x1.85x1.97x1.98x1.93x1.23x1.40x1.41x1.34x1.21x1.08x1.41x1.52x1.51x1.42x
Quick Ratio1.32x1.56x1.05x1.18x1.12x1.52x1.95x1.81x1.53x2.05x1.87x1.77x1.42x1.28x1.36x1.24x1.39x1.28x1.32x1.37x1.36x0.77x0.91x0.86x0.89x0.80x0.74x1.00x1.10x1.04x1.06x
Cash Conversion Cycle116.89119.94118.52123.38183.19140.85109.91102.9999.0294.9999.3119.06117.67279.42172.82161.29150.57172.69148.46155.51141.51-18-36.534.52-26.99139.060.7416.290.6113.47159.36
Total Non-Current Liabilities10.02B10.98B12.25B13.3B17.65B20.16B7.96B7.05B5.04B5.17B4.52B6.35B11.95B11.49B8.65B7.39B6.65B5.47B5.54B4.57B4.8B4.26B6.16B6.63B5.69B3.29B2.7B3.6B4.2B3.53B2.65B
Long-Term Debt8.62B9.68B10.37B11.09B15.23B17.15B5.79B4.81B3.48B3.51B2.78B3.92B7.33B8.13B5.58B4.75B4.36B3.44B3.36B2.66B2.57B2.41B3.93B4.42B4.4B2.49B1.73B2.6B3.1B2.63B1.7B
Capital Lease Obligations886M244M243M265M447M522M501M510M000000000000000029M000000
Deferred Tax Liabilities245M245M103M403M661M962M143M192M215M280M93M195M0000000000000218M160M311M461M316M255M
Other Non-Current Liabilities1.2B783M1.49B1.51B1.27B1.45B1.5B1.49B1.34B1.39B1.65B2.23B4.61B3.36B3.07B2.64B2.29B2.03B2.18B1.9B2.24B1.85B2.22B2.21B1.26B588M816M684M646M580M697M
Total Liabilities13.61B13.95B18.76B19.81B22.39B24.4B11.29B10.28B7.85B8B7.27B12.1B17.98B16.74B13.41B12.24B10.69B9.93B9.18B8.38B8.41B8.43B10.44B10.43B9.54B6.59B6.07B6.3B7.03B6.09B5.09B
Total Debt9.67B10B13.45B14.11B17.2B18.31B6.8B5.96B3.48B3.51B2.78B6.51B9.03B9.17B5.93B5.2B4.39B4.15B3.76B3.09B2.8B3.34B4.29B4.57B4.65B2.69B2.36B2.86B3.37B2.78B2.04B
Net Debt7.52B8.04B11.69B11.04B15.48B15.36B3.07B2.63B1.65B118M-19M4.29B6.1B6.43B2.66B2.29B1.7B1.36B1.63B550M316M2.5B3.19B3.65B3.48B2.1B1.78B2.25B2.66B2.31B1.28B
Debt / Equity1.56x1.64x1.91x1.67x2.92x2.01x0.78x0.75x0.44x0.39x0.34x0.73x1.11x1.08x0.85x0.76x0.65x0.56x0.60x0.45x0.45x0.78x1.16x1.40x1.58x0.72x0.89x0.85x1.19x1.06x0.82x
Debt / EBITDA14.24x14.86x13.30x8.35x-8.26x2.79x2.33x1.48x1.72x1.80x5.39x6.24x8.10x1.68x1.44x1.56x1.18x1.18x1.12x1.16x1.50x2.87x2.54x2.36x1.63x1.65x1.88x2.48x2.31x1.62x
Net Debt / EBITDA11.07x11.94x11.56x6.53x-6.93x1.26x1.03x0.70x0.06x-0.01x3.55x4.22x5.69x0.75x0.63x0.60x0.39x0.51x0.20x0.13x1.13x2.13x2.02x1.77x1.28x1.25x1.48x1.96x1.92x1.02x
Interest Coverage-0.70x-0.74x0.29x1.48x-6.86x6.39x9.44x9.74x18.39x13.94x56.66x3.93x3.93x3.42x26.12x31.53x17.43x24.37x17.64x18.05x18.23x12.97x14.53x13.87x24.20x13.92x10.08x-5.26x-4.26x
Total Equity6.18B6.1B7.02B8.47B5.89B9.12B8.73B7.91B7.87B9.12B8.28B8.87B8.16B8.49B6.98B6.83B6.8B7.42B6.23B6.92B6.27B4.3B3.71B3.27B2.94B3.76B2.66B3.35B2.84B2.62B2.5B
Equity Growth %-52.28%-13.13%-17.05%43.65%-35.37%4.53%10.29%0.58%-13.71%10.1%-6.6%8.69%-3.89%21.61%2.2%0.47%-8.41%19.12%-9.93%10.27%45.89%16.03%13.16%11.4%-21.77%41.29%-20.58%17.93%8.4%4.59%-32.4%
Book Value per Share11.9311.8913.7716.7411.7017.9516.8815.2414.4116.4315.0316.1514.9115.4612.5511.9211.4412.089.7810.579.566.836.005.676.336.694.495.674.914.644.54
Total Shareholders' Equity6.21B6.13B6.96B8.4B5.83B9.08B8.69B7.88B7.84B9.12B8.29B8.85B8.12B8.46B6.94B6.58B6.57B7.19B6.23B6.92B6.27B4.3B3.71B3.27B2.94B3.76B2.66B3.35B2.84B2.62B2.5B
Common Stock683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M648M648M649M627M609M298M294M291M00
Retained Earnings13.81B13.71B14.93B16.11B14.05B17.07B16.33B15.72B15.07B14.48B14.2B9.68B13.23B11.85B10.89B9.43B7.92B7.34B5.79B4.38B3.27B2.85B2.26B2.15B1.69B1.09B853M1.42B990M1.01B1.02B
Treasury Stock-10.71B-10.87B-11.06B-11.23B-11.39B-11.49B-11.05B-10.76B-9.99B-7.98B-8B-7.65B-7.99B-7.91B-7.59B-6.72B-5.66B-4.74B-3.9B-2.5B-1.43B-1.15B-1.51B-1.86B-1.33B-328M-349M-269M-210M00
Accumulated OCI-3.82B-3.75B-4.01B-3.55B-3.83B-3.38B-3.31B-3.71B-3.82B-4B-4.56B224M-3.65B-1.98B-2.81B-2.59B-2.14B-1.78B-1.89B-940M-1.43B-1.5B-1.29B-1.43B-1.27B-432M-649M-374M-296M00
Minority Interest-27M-27M60M66M62M44M37M30M22M-8M-10M19M36M23M40M243M229M229M0000000000000

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Elevated leverage and spin-off execution

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Shrinking Amid Divestiture

Total assets contracted from $27.8B in Q1 2024 to $19.8B in Q2 2026, per quarterly filings, reflecting the Vantive spin-off and debt reduction, though equity has stabilized around $6B.

The balance sheet has undergone a significant deleveraging, with total debt falling from $14.2B to $9.7B over the period, as reported in financial statements. This suggests a strategic shift toward a leaner asset base, but the concurrent decline in equity from $8.2B to $6.2B indicates that retained earnings have been pressured by cumulative losses. The trajectory appears to be one of deliberate contraction, likely aimed at improving financial flexibility ahead of the Vantive separation.

Leverage Elevated Despite Debt Reduction

Debt-to-equity remains high at 1.56 in Q2 2026, down from 1.72 in Q1 2024, as per balance sheet data, but cash-to-debt of 0.18 signals limited liquidity buffer against obligations.

While total debt has decreased by roughly $4.5 billion since early 2024, the leverage ratio remains elevated compared to peers like BDX (0.76) and BSX (0.51), based on reported figures. The high debt load appears to be a legacy of the Hillrom acquisition, and the company's ability to service this debt is constrained by thin operating margins. Investors should monitor refinancing risk, as a portion of this debt may mature in a higher interest rate environment, potentially increasing interest expense and pressuring cash flows.

Asset Mix Shifting Toward Intangibles

Goodwill and intangibles represent roughly 25% of total assets at $4.9B in Q2 2026, as reported in financial statements, while net PPE has declined to $3.2B, indicating a lighter fixed-asset base.

The reduction in net PPE from $4.9B in Q2 2024 to $3.2B in Q2 2026, per balance sheet data, suggests divestitures or impairments, possibly related to the Vantive spin-off. Goodwill has also decreased from $6.4B to $4.9B, which may indicate impairment charges or asset reclassifications. This shift implies a move toward an asset-light model, but the remaining goodwill carries impairment risk if the company's market value does not recover.

Equity Erosion Reflects Cumulative Losses

Retained earnings fell from $16.0B in Q1 2024 to $13.8B in Q2 2026, as per balance sheet data, reflecting net losses and dividend payments, while equity has stabilized near $6B.

The decline in retained earnings of over $2 billion over the period, as reported in financial statements, is consistent with the negative net income in several quarters, including a $1.1 billion loss in Q4 2025. The company has maintained its dividend despite these losses, which may signal management's commitment to shareholder returns but also reduces the capital available for debt reduction. The equity base appears adequate but is not growing organically, suggesting reliance on operational turnaround rather than retained earnings accumulation.

Liquidity Buffer Thin Relative to Debt

Current ratio improved to 1.95 in Q2 2026 from 1.48 in Q1 2024, per balance sheet data, but cash of $2.1B covers only 22% of total debt, indicating limited liquidity cushion.

The current ratio has strengthened, suggesting improved short-term solvency, but the absolute cash position remains modest relative to the $9.7B debt load, as reported in financial statements. The cash-to-debt ratio of 0.18 is low compared to peers like BSX (0.20) and EW (0.07), but BAX's cash balance is higher in absolute terms. However, given the ongoing spin-off and potential restructuring costs, the liquidity buffer may be tested, and investors should monitor whether operating cash flows can service debt without additional borrowing.

Spin-Off Distorts Balance Sheet Comparability

The Vantive separation has reclassified assets and liabilities, as noted in recent filings, making historical balance sheet comparisons misleading and potentially understating the true leverage of continuing operations.

The reported debt-to-equity ratio of 1.56 may not fully capture the financial obligations of the continuing business, as the spin-off involves complex accounting for discontinued operations and asset transfers, according to company disclosures. Additionally, the absence of deferred revenue in most quarters suggests that the company's revenue recognition for capital equipment may be lumpy, but this is not a major concern. The key distortion is the potential understatement of debt if certain liabilities are transferred to Vantive, which could make the remaining balance sheet appear healthier than it is. Investors should adjust for these effects when assessing the company's financial health.

BAX — Frequently Asked Questions

Quick answers to the most common questions about buying BAX stock.

What are the total assets of Baxter International Inc. (BAX)?

As of 2025, Baxter International Inc. (BAX) had total assets of $20.05B including $6.87B in current assets.

How much debt does Baxter International Inc. (BAX) have?

Baxter International Inc. (BAX) carries total debt of $10.00B, offset by $1.97B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Baxter International Inc.?

Baxter International Inc. (BAX) has total shareholders' equity (book value) of $6.13B ($11.89 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Baxter International Inc.'s current ratio and liquidity?

Baxter International Inc. (BAX) reported a current ratio of 2.31x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.